SENNA-S (Advance Pharmaceutical Inc.)
Welcome to the PulseAid listing for the SENNA-S drug offered from Advance Pharmaceutical Inc.. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Advance Pharmaceutical Inc. |
| NON-PROPRIETARY NAME: | Senna and Docusate Sodium Tablets, 8.6 mg and 50 mg |
| SUBSTANCE NAME: | SENNOSIDES; DOCUSATE SODIUM |
| TYPE: | HUMAN OTC DRUG |
| PHARMA CLASS: | |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | OTC MONOGRAPH NOT FINAL |
| START MARKETING DATE: | 2017-02-01 |
| END MARKETING DATE: | 0000-00-00 |
SENNA-S HUMAN OTC DRUG Details:
| Item Description | SENNA-S from Advance Pharmaceutical Inc. |
| LABELER NAME: | Advance Pharmaceutical Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 8.6; 50(mg/1; mg/1) |
| START MARKETING DATE: | 2017-02-01 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 17714-124_5cc973b8-e563-2f6c-e053-2a91aa0a9ab8 |
| PRODUCT NDC: | 17714-124 |
| APPLICATION NUMBER: | part334 |
Other SENNOSIDES; DOCUSATE SODIUM Pharmaceutical Manufacturers / Labelers:
